The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: The L.I.F.T. study
Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: Achievements and limitations
Roehrborn CG: Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Rev Urol 2008;10:14.
Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: The Triumph Project
Verhamme KM, Dieleman JP, Bieumink GS et al: Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph Project. Eur Urol 2003;58:539.
American Urological Association Education and Research Inc
Roehrborn CG, McConnell JD, Bary MJ et al: American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2003.
American Urological Association Education and Research Inc
McVary KT, Roehrborn CG, Avins AL et al: American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2010.
Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: A systematic review with metaanalysis from 2002 to 2012
Thangasamy IA, Chalasani V, Bachmann A et al: Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with metaanalysis from 2002 to 2012. Eur Urol 2012;62:315.
Safety and feasibility of the Prostatic Urethral Lift: A novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)
Woo HH, Chin PT, McNicholas TA et al: Safety and feasibility of the Prostatic Urethral Lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 2011;108:82.
Prostatic Urethral Lift: Two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia
Chin PT, Boiton DM, Jack G et al: Prostatic Urethral Lift: two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia. Urology 2012;79:5.
Preservation of sexual function with the Prostatic Urethral Lift: A novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia
Woo HH, Bolton DM, Laborde E et al: Preservation of sexual function with the Prostatic Urethral Lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Sex Med 2012;9:368.
A sham controlled trial of transurethral microwave therapy with subsequent treatment of the control group
Bdesha A, Bunce C, Snell M et al: A sham controlled trial of transurethral microwave therapy with subsequent treatment of the control group. J Urol 1994;152:453.
A highefficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: Results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial
Larson TR, Blute ML, Bruskewitz RC et al: A highefficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology 1998;51:731.
Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: Results of a randomized, double-blind, multicenter, shamcontrolled trial
Roehrborn CG, Preminger G, Newhall P et al: Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, shamcontrolled trial. Urology 1998;51:19.
Relevance and variability of the severity of incontinence and increased daytime and nighttime voiding frequency, associated with quality of life in men with lower urinary tract symptoms
Haltbakk J, Hanestad BR and Hunskaar S: Relevance and variability of the severity of incontinence and increased daytime and nighttime voiding frequency, associated with quality of life in men with lower urinary tract symptoms. BJU Int 2005;96:83.
How important are men's lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL) ?
Haltbakk J, Hanestad BR and Hunskaar S: How important are men's lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL) ? Qual Life Res 2005;14:1733.
Waning sexual functionethe most important disease-specific distress for patients with prostate cancer
Helgason AR, Adolfsson J, Dickman P et al: Waning sexual functionethe most important disease-specific distress for patients with prostate cancer. Br J Cancer 1996;73:1417.
A crossnational study of subjective sexual well-being among older women and men: Findings from the Global Study of Sexual Attitudes and Behaviors
Laumann EO, Paik A, Glasser DB et al: A crossnational study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitudes and Behaviors. Arch Sex Behav 2006;35:145.